• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SCA7基因的克隆揭示了一个高度不稳定的CAG重复序列扩增。

Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion.

作者信息

David G, Abbas N, Stevanin G, Dürr A, Yvert G, Cancel G, Weber C, Imbert G, Saudou F, Antoniou E, Drabkin H, Gemmill R, Giunti P, Benomar A, Wood N, Ruberg M, Agid Y, Mandel J L, Brice A

机构信息

INSERM U289, Hôpital de la Salpêtrière, Paris, France.

出版信息

Nat Genet. 1997 Sep;17(1):65-70. doi: 10.1038/ng0997-65.

DOI:10.1038/ng0997-65
PMID:9288099
Abstract

The gene for spinocerebellar ataxia 7 (SCA7) has been mapped to chromosome 3p12-13. By positional cloning, we have identified a new gene of unknown function containing a CAG repeat that is expanded in SCA7 patients. On mutated alleles, CAG repeat size is highly variable, ranging from 38 to 130 repeats, whereas on normal alleles it ranges from 7 to 17 repeats. Gonadal instability in SCA7 is greater than that observed in any of the seven known neuro-degenerative diseases caused by translated CAG repeat expansions, and is markedly associated with paternal transmissions. SCA7 is the first such disorder in which the degenerative process also affects the retina.

摘要

脊髓小脑共济失调7型(SCA7)基因已被定位到3号染色体的p12 - 13区域。通过定位克隆,我们鉴定出一个功能未知的新基因,该基因包含一个CAG重复序列,在SCA7患者中此重复序列发生了扩增。在突变等位基因上,CAG重复序列的大小高度可变,范围从38到130个重复,而在正常等位基因上,其范围为7到17个重复。SCA7中的性腺不稳定性大于由翻译后的CAG重复序列扩增引起的七种已知神经退行性疾病中的任何一种,并且与父系遗传显著相关。SCA7是第一种其退行性病变过程也累及视网膜的此类疾病。

相似文献

1
Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion.SCA7基因的克隆揭示了一个高度不稳定的CAG重复序列扩增。
Nat Genet. 1997 Sep;17(1):65-70. doi: 10.1038/ng0997-65.
2
Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats.脊髓小脑共济失调2型基因的克隆揭示了一个对CAG/谷氨酰胺重复序列扩增高度敏感的基因座。
Nat Genet. 1996 Nov;14(3):285-91. doi: 10.1038/ng1196-285.
3
A SCA7 CAG/CTG repeat expansion is stable in Drosophila melanogaster despite modulation of genomic context and gene dosage.尽管基因组背景和基因剂量有所调节,但脊髓小脑共济失调7型(SCA7)的CAG/CTG重复序列在黑腹果蝇中是稳定的。
Gene. 2005 Feb 28;347(1):35-41. doi: 10.1016/j.gene.2004.12.008.
4
Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2.2型脊髓小脑共济失调中正常双等位基因三核苷酸重复序列的中度扩增。
Nat Genet. 1996 Nov;14(3):269-76. doi: 10.1038/ng1196-269.
5
Unstable triplet repeat and phenotypic variability of spinocerebellar ataxia type 1.1型脊髓小脑共济失调的不稳定三联体重复序列与表型变异性
Ann Neurol. 1996 Apr;39(4):500-6. doi: 10.1002/ana.410390412.
6
Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT.运用重复序列扩张直接鉴定与克隆技术(DIRECT)鉴定2型脊髓小脑共济失调基因。
Nat Genet. 1996 Nov;14(3):277-84. doi: 10.1038/ng1196-277.
7
Rapid cloning of expanded trinucleotide repeat sequences from genomic DNA.从基因组DNA中快速克隆扩增的三核苷酸重复序列。
Nat Genet. 1998 Jan;18(1):72-5. doi: 10.1038/ng0198-72.
8
Molecular genetic analysis of autosomal dominant cerebellar ataxia with retinal degeneration (ADCA type II) caused by CAG triplet repeat expansion.由CAG三联体重复扩增引起的常染色体显性遗传性小脑共济失调伴视网膜变性(II型常染色体显性小脑共济失调)的分子遗传学分析
Hum Mol Genet. 1998 Feb;7(2):177-86. doi: 10.1093/hmg/7.2.177.
9
Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I.1型脊髓小脑共济失调中存在导致代际CAG重复序列不稳定的机制的证据。
Nat Genet. 1993 Nov;5(3):254-8. doi: 10.1038/ng1193-254.
10
Spinocerebellar ataxia type 7 (SCA7) - correlations between phenotype and genotype in one large Belgian family.7型脊髓小脑共济失调(SCA7)——一个比利时大家庭中表型与基因型的相关性
J Neurol Sci. 1999 Sep 15;168(1):37-46. doi: 10.1016/s0022-510x(99)00176-8.

引用本文的文献

1
Evaluating Glial Fibrillary Acidic Protein and Neurofilament Light as Potential Biomarkers for Spinocerebellar Ataxia 7.评估胶质纤维酸性蛋白和神经丝轻链作为脊髓小脑共济失调7型潜在生物标志物的作用。
Int J Mol Sci. 2025 May 24;26(11):5070. doi: 10.3390/ijms26115070.
2
Multi-omic insights into molecular mechanism and therapeutic targets in spinocerebellar ataxia type 7.对7型脊髓小脑共济失调分子机制和治疗靶点的多组学见解
Mol Ther Nucleic Acids. 2024 Dec 5;36(1):102414. doi: 10.1016/j.omtn.2024.102414. eCollection 2025 Mar 11.
3
Increased nuclear import characterizes aberrant nucleocytoplasmic transport in neurons from patients with spinocerebellar ataxia type 7.
核输入增加是7型脊髓小脑共济失调患者神经元中异常核质转运的特征。
Front Mol Neurosci. 2024 Nov 22;17:1478110. doi: 10.3389/fnmol.2024.1478110. eCollection 2024.
4
Dysregulation of zebrin-II cell subtypes in the cerebellum is a shared feature across polyglutamine ataxia mouse models and patients.小脑中 zebrin-II 细胞亚型的失调是多聚谷氨酰胺相关共济失调小鼠模型和患者的共同特征。
Sci Transl Med. 2024 Nov 6;16(772):eadn5449. doi: 10.1126/scitranslmed.adn5449.
5
Current Overview of Spinocerebellar Ataxia Type 7 in Mexican Population: Challenges in Specialized Care for a Rare Disease.脊髓小脑性共济失调 7 型在墨西哥人群中的现状概述:罕见病专科护理面临的挑战。
Int J Mol Sci. 2024 Oct 6;25(19):10750. doi: 10.3390/ijms251910750.
6
Respiratory neuropathology in spinocerebellar ataxia type 7.脊髓小脑共济失调 7 型的呼吸神经病理学。
JCI Insight. 2024 Jul 18;9(18):e170444. doi: 10.1172/jci.insight.170444.
7
The Role of Protein Quantity Control in Polyglutamine Spinocerebellar Ataxias.蛋白质量控制在多聚谷氨酰胺小脑共济失调中的作用。
Cerebellum. 2024 Dec;23(6):2575-2592. doi: 10.1007/s12311-024-01722-w. Epub 2024 Jul 25.
8
Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration.多聚谷氨酰胺(PolyQ)疾病:探索神经退行性变的全景。
ACS Chem Neurosci. 2024 Aug 7;15(15):2665-2694. doi: 10.1021/acschemneuro.4c00184. Epub 2024 Jul 12.
9
Altered Metabolic Signaling and Potential Therapies in Polyglutamine Diseases.多聚谷氨酰胺疾病中代谢信号的改变及潜在治疗方法
Metabolites. 2024 May 31;14(6):320. doi: 10.3390/metabo14060320.
10
CAG repeat mosaicism is gene specific in spinocerebellar ataxias.CAG重复嵌合现象在脊髓小脑性共济失调中具有基因特异性。
Am J Hum Genet. 2024 May 2;111(5):913-926. doi: 10.1016/j.ajhg.2024.03.015. Epub 2024 Apr 15.